It’s almost a new year. But the never-ending saga of Bond 25, aka No Time to Die, continues. Naturally the blog has questions.
Will we finally get to see No Time to Die in 2021?
You’d think so. Vaccines for COVID-19 are being rolled out. By around mid-year or so, they should be available to a big chunk of the population.
Will we get to see No Time to Die in April?
That’s the more germane question. Right now, COVID-19 is causing havoc. Los Angeles-area hospitals are looking at rationing care because they are swamped with COVID cases. The U.K, in December imposed new lockdowns because of a new variant of the virus.
Can things actually improve enough three months from now to permit a traditional theater release (which is what Eon Productions boss Barbara Broccoli wants)?
Meanwhile, Universal (which is handling international distribution for No Time to Die) said Dec. 28 that it’s delaying the release of the animated film Boss Baby from March 26 to Sept. 17. That suggests Universal is nervous about a late March/early April release date.
Which will happen first: Theatrical release of No Time to Die, or an announced sale of Metro-Goldwyn-Mayer?
MGM, Bond’s home studio, reportedly has put itself for sale. If No Time to Die really comes out in April, it might be tough to have a sale organized. If the 25th James Bond film (and its almost $290 million price tag) gets delayed again, a sale may happen first.
Happy New Year.
Filed under: James Bond Films | Tagged: Bond 25, Boss Baby, COVID-19, Eon Productions, Metro-Goldwyn-Mayer, No Time to Die, Universal | 1 Comment »
The Spy Command 